TNFSF13B and myalgic encephalomeyelitis/chronic fatigue syndrome: Although statistically significant, the difference in baseline serum BAFF levels was relatively modest in magnitude and there was a broad overlap between ME/CFS patients and healthy controls; thus, serum BAFF level is not suitable as a biomarker for the disease.